WHO ICTRP trial
A trial of bortezomib with R-CHOP for diffuse large B cell lymphoma (DLBCL)
EUCTR2010-022422-32-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2010-022422-32-GB |
|---|---|
| Public title | A trial of bortezomib with R-CHOP for diffuse large B cell lymphoma (DLBCL) |
| Scientific title | A randomised evaluation of molecular guided therapy for diffuse large B-cell lymphoma with Bortezomib - REMoDL-B v1.0 |
| Primary sponsor | University Hospital Southampton NHS Foundation Trust |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United Kingdom |
| Conditions | Diffuse Large B-cell Lymphoma |
| Interventions | Trade Name: Velcade (Bortezomib) Product Name: Bortezomib (Velcade) Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: Bortezomib Concentration unit: mg/m2 milligram(s)/square meter Concentration type: equal… |
| Registration date | Aug 11, 2010 |
| Target size | 940 |
| Secondary IDs | RHMCAN0749;ISRCTN51837425 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: